Community/Retail

Three abstracts that evaluate the efficacy and safety of cantharidin (VP-102) were presented by Verrica Pharmaceuticals at the 39th Annual Fall Clinical Dermatology Conference in Las Vegas, Nevada.

One highlight of the American Society for Emergency Contraception (ASEC) EC Jamboree was the key clinical discussions centered on drug interactions between emergency contraception and other hormonal contraceptives, including ulipristal acetate.

Top news of the day from across the health care landscape.

Pending results of the California Practice Standards and Jurisprudence Exam (CPJE) have been invalidated for 1400 applicants that recently took the test, due to a cheating issue.

Baloxavir marboxil (Xofluza, Genentech) is the first antiviral medication indicated for patients at high risk of developing influenza-related complications.

Nine widely-used medications have experienced substantial price growth since 2016, adding $5.1 billion to overall drug spending.

Kyowa Kirin’s istradefylline (Nourianz) is now available in the United States as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) that are experiencing “off” episodes.

Top news of the day from across the health care landscape.

Officials from the FDA have approved Noven Pharmaceuticals, Inc.’s asenapine (Secuado) transdermal system, which is the first-and-only transdermal patch for the treatment of adults with schizophrenia, according to the company.

As pharmacists continue to provide more direct patient-centric services, the case for technicians to take on managing pharmacy inventory becomes more reasonable.

Today is National Pharmacy Technician Day, and pharmacists are sharing how valuable technicians are to them.

In the wake of California’s drug transparency law, an analysis by state health officials on pricing trends found that drug companies raised the whole acquisition cost dramatically for many drugs.

Measles cases in the United States have reached a record high in 2019, according to a recent CDC report.

The Rite Aid Foundation is awarding $2.3 million to Children’s Miracle Network Hospitals through its KidCents Grant Program.

A study by the CDC has found that only approximately half of pregnant women reported receiving the influenza, and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines.

Lasmiditan (Reyvow, Eli Lilly) resolved pain and most bothersome symptoms within 2 hours of treatment in patients with migraine.

“Sesame Street” has joined the fight against opioid addiction by creating a storyine to help educate children about the opioid epidemic and how it affects families.

This article is the third in a series on difficult to pronounce drug names.

Top news of the day from across the health care landscape.

The findings of the retrospective cohort study were presented in a poster at IDWeek 2019.

Suzy Soliman, PharmD, founder of the Pharmacist Moms Group, discusses how Cardinal Health has supported Women Pharmacist Day.

Prescription medications and other health care items, including vitamins and supplements, eyewear, and natural medicine, such as pharmaceutical-grade CBD oil, is being delivered in the Dallas-Fort Worth (DFW) area with service to homes and offices.

Top news of the day from across the health care landscape.

Brolucizumab is the most clinically advanced humanized single-chain antibody fragment. This type of antibody is highly sought after due to their small size, enhanced tissue penetration, rapid clearance from systemic circulation, and drug delivery characteristics.

Trifarotene is the only topical retinoid that selectively targets retinoic acid receptor (RAR) gamma, the most common RAR found in the skin. The cream is also the first topical treatment specifically studied and proven to treat both facial (forehead, cheeks, nose, and chin) and truncal (chest, shoulders, and back).

Suzy Soliman, PharmD, discusses why October 12 was chosen to recognize Women Pharmacist Day.

A new study by Prime Therapeutics LLC has shown a sharp increase in the number of drug "super spenders," defined by the researchers as members with pharmacy and medical drug therapy claims of $250,000 or more annually.

A first-in-human trial evaluating the safety, pharmacokinetics, and fecal microbiome effects of a novel DNA polIIIC inhibitor demonstrated the antibacterial’s promise as a potential treatment alternative to vancomycin for the treatment of Clostridioides difficile.

The FDA has awarded a cooperative agreement grant to the National Association of Boards of Pharmacy to develop a 3-year pilot project for a data-sharing system to improve oversight of compounding pharmacies.

The FDA is continuing to test ranitidine products from multiple manufacturers following the discovery of impurities in low levels in some medicines, including Zantac.